[rank_math_breadcrumb]
TMCC is the first medical cannabis clinic to be awarded ‘Good’ by CQC
Disclaimer
The content provided on this blog is intended for educational purposes only and should not be construed as medical advice. We strongly advise readers to seek guidance from a qualified healthcare professional regarding any medical concerns.
To reflect its medicinal nature rather than recreational use, we prefer the term ‘medical cannabis’ over terms such as ‘marijuana’, “grass”. or ‘dope’ which may carry negative connotations.
The opinions expressed in the blog belong to the respective authors, who are not medical professionals, and may not necessarily align with those of Lyphe Clinic. Lyphe Clinic does not endorse any specific products or services mentioned, except those provided through Lyphe Clinic.
Readers should be aware that the legality of medical cannabis varies by location, and this disclaimer may be subject to periodic updates.
We are pleased to announce that Lyphe has been awarded the first rated ‘Good’ cannabis clinic in the UK by health and social care regulator Care Quality Commission (CQC).
Lyphe, which cares for more than 60% of all medical cannabis patients in the UK has passed with a ‘Good’ rating after a thorough inspection by CQC which regulates to ensure patients are provided with safe, effective, compassionate, and high-quality care. This was the first inspection of a cannabis clinic by the CQC.
TMCC was awarded one of four licences to trade as a cannabis clinic by CQC in 2019, and has since dedicated its focus to opening access for patients to receive care and treatment from the finest consultants across a number of medical areas including Pain and Psychiatry.
Over half of all doctors that are currently prescribing medical cannabis, are working at TMCC which operates completely via telemedicine services, and due to patient number growth five new doctors are being onboarded monthly.
Chief Medical Officer, Dr Sunny Nayee said of the CQC rating: “We are delighted to receive this rating from CQC, as it shows that the hard work from the doctors and support staff has all been worth it. The industry is not by any means mature yet and we are always looking for ways to improve how we do things for the greater good of the patient. For us, patient safety and efficacious treatment is the central pillar of the clinic, and I am proud this has been noticed by CQC.”
Group Managing Director of LYPHE Group, Jonathan Nadler said: “I would like to congratulate everyone at TMCC for playing their part in making the clinic a critical care operator for patients seeking medical cannabis. We have set the standard for all other cannabis clinics to now follow.”
Book an online appointment
Lyphe is your patient-first path to wellness, so book an appointment with one of our medical cannabis expert Doctors and get the relief you need.
Related Insights
Whilst you’re here you might also like to read…
